Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03023904
Title Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Vanderbilt-Ingram Cancer Center

lung non-small cell carcinoma



Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST